NASDAQ:ACRV | Balance Sheet | Acrivon Therapeutics, Inc.

Complete source-backed balance-sheet history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Balance Sheet

DateCash and equivalentsCurrent securitiesReceivablesInventoryOther current assetsCurrent assetsProperty, plant and equipmentOther noncurrent assetsTotal assetsAccounts payableCurrent liabilitiesLong-term debtOther noncurrent liabilitiesTotal liabilitiesShareholder equity
2026-06-30$41.42M$48.54M$91.49M$4.25M$1.18M$99.09M$861,000.00$11.45M$12.43M$86.67M
2026-03-31$34.06M$63.67M$99.22M$4.65M$1.51M$107.83M$1.16M$11.05M$12.32M$95.52M
2025-12-31$41.5M$77.08M$120.45M$4.89M$1.65M$129.72M$2.28M$15.66M$17.2M$112.52M
2025-09-30$35.41M$93.85M$130.36M$5.19M$1.65M$145.3M$996,000.00$14.89M$16.7M$128.6M
2025-06-30$41.9M$95.53M$138.41M$5.07M$1.65M$158.58M$1.16M$13.43M$15.55M$143.04M
2025-03-31$39.15M$110.48M$151.33M$4.68M$1.65M$176.35M$3.69M$13.55M$15.96M$160.39M
2024-12-31$39.82M$139.66M$181.63M$4.47M$1.65M$196.59M$758,000.00$17.21M$19.8M$176.79M
2024-09-30$43.42M$144.04M$188.98M$4.67M$1.18M$214.68M$1.51M$14.82M$17.79M$196.89M
2024-06-30$46.01M$134.53M$182.36M$3.47M$230.59M$1.26M$11.28M$14.53M$216.06M
2024-03-31$24.61M$85.37M$112.14M$3.41M$120.52M$2.06M$9.04M$12.54M$107.98M
2023-12-31$36.02M$91.44M$129.69M$3.48M$251,000.00$138.27M$5.05M$13.3M$17.07M$121.2M
2023-09-30$29.86M$112.23M$144.49M$2M$151.09M$1.5M$9.3M$12.94M$138.15M
2023-06-30$38.07M$112.88M$153.28M$1.98M$160.05M$1.27M$7.02M$10.87M$149.18M
2023-03-31$27.49M$92.72M$123.96M$1.99M$170.2M$1.37M$5.68M$9.73M$160.47M
2022-12-31$29.52M$98.23M$132.1M$2.09M$181.23M$904,000.00$6.52M$10.75M$170.48M
2022-09-30$32.08M$78.67M$2.15M$87.71M$1.98M$6.39M$10.81M-$45.62M
2022-06-30$83.86M-$36.58M
2022-03-31$90.77M-$30.99M
2021-12-31$99.6M$100.41M$290,000.00$106.59M$964,000.00$2.91M$7.88M-$23.81M
2021-09-30$3.61M-$19.77M
2021-06-30-$17.36M
2021-03-31-$14.84M
2020-12-31-$8.41M